[go: up one dir, main page]

NZ304538A - Process for producing a modified recombinant protein in a host cell comprising preparing a single vector encoding both the exogenous protein and an enzyme capable of modifying the exogenous protein - Google Patents

Process for producing a modified recombinant protein in a host cell comprising preparing a single vector encoding both the exogenous protein and an enzyme capable of modifying the exogenous protein

Info

Publication number
NZ304538A
NZ304538A NZ304538A NZ30453896A NZ304538A NZ 304538 A NZ304538 A NZ 304538A NZ 304538 A NZ304538 A NZ 304538A NZ 30453896 A NZ30453896 A NZ 30453896A NZ 304538 A NZ304538 A NZ 304538A
Authority
NZ
New Zealand
Prior art keywords
protein
exogenous protein
modifying
preparing
producing
Prior art date
Application number
NZ304538A
Inventor
Pradip Mukerji
Jennifer Marie Thurmond
Stig Lennart Hansson
Original Assignee
Abbott Lab
Symbicom Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, Symbicom Ab filed Critical Abbott Lab
Publication of NZ304538A publication Critical patent/NZ304538A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NZ304538A 1995-02-27 1996-02-27 Process for producing a modified recombinant protein in a host cell comprising preparing a single vector encoding both the exogenous protein and an enzyme capable of modifying the exogenous protein NZ304538A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39499995A 1995-02-27 1995-02-27
PCT/US1996/002623 WO1996027017A1 (en) 1995-02-27 1996-02-27 A method for expressing modified recombinant proteins in a bacterial system

Publications (1)

Publication Number Publication Date
NZ304538A true NZ304538A (en) 1999-08-30

Family

ID=23561282

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ304538A NZ304538A (en) 1995-02-27 1996-02-27 Process for producing a modified recombinant protein in a host cell comprising preparing a single vector encoding both the exogenous protein and an enzyme capable of modifying the exogenous protein

Country Status (5)

Country Link
EP (1) EP0812361A1 (en)
JP (1) JPH11500918A (en)
CA (1) CA2213857A1 (en)
NZ (1) NZ304538A (en)
WO (1) WO1996027017A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807702A (en) * 1995-02-27 1998-09-15 Abbott Laboratories Method for expressing phosphorylated recombinant human β-casein in a bacterial system
US6071718A (en) * 1996-11-27 2000-06-06 Abbott Laboratories Methods of producing a recombinant protein
US6287866B1 (en) 1996-11-27 2001-09-11 Abbott Laboratories β-casein expressing constructs
US6121421A (en) * 1998-08-21 2000-09-19 Abbott Laboratories Methods for isolating recombinant β-casein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178863A1 (en) * 1984-10-15 1986-04-23 Schering Corporation Novel expression systems utilizing bacteriophage T7 promoters and gene sequences
ATE141644T1 (en) * 1990-02-26 1996-09-15 Univ Washington PROTEIN-N-MYRISTOYLATION PROCESS
JP4236698B2 (en) * 1990-11-26 2009-03-11 ジェネティックス インスティチュート，リミテッド ライアビリティ カンパニー Expression of PACE in host cells and uses thereof
DE69222013T2 (en) * 1991-12-16 1998-01-29 Ciba Geigy Ag Endoplasmic reticulum-constant recombinant dibasic endoprotease and its uses
US5512434A (en) * 1992-12-14 1996-04-30 The United States Of America As Represented By The Department Of Health And Human Services Expression cloning of a human phosphatase

Also Published As

Publication number Publication date
CA2213857A1 (en) 1996-09-06
JPH11500918A (en) 1999-01-26
WO1996027017A1 (en) 1996-09-06
EP0812361A1 (en) 1997-12-17

Similar Documents

Publication Publication Date Title
HUP9800901A3 (en) Process, medium and cell culture system for the preparation of recombinant factor viii in a protein free medium
HUT51672A (en) Process for producing recombinant expression dna vectors and dna molecules encoding deacetoxycefalosporin c synthetase enzyme
ZA9610384B (en) Process for the preparing recombinant protein in e coll by means of high cell density fermentation
EP1688500A3 (en) Overexpression of phytase genes in yeast systems
EP0330451A3 (en) A cdna coding for human normal serum albumin a, and a process for production of the albumin
AU3321595A (en) Recombinant production of biologically active peptides and proteins
AU9319198A (en) Methods and vector constructs useful for production of recombinant aav
AU3199695A (en) Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same
AU3131195A (en) Vectors and transformed host cells for recombinant protein production at reduced temperatures
AU6428890A (en) Therapeutic peptides and proteins
IL96143A0 (en) Methods for the production of proteins and polypeptides and for enhancement of cell growth
HU9602894D0 (en) Non-splicing variants of gp350/220
NZ304538A (en) Process for producing a modified recombinant protein in a host cell comprising preparing a single vector encoding both the exogenous protein and an enzyme capable of modifying the exogenous protein
HU904145D0 (en) Process for producing new proteins and peptides of antigenous activity and fipv vaccines
AU2085195A (en) Gene coding for igg-fc-binding protein
AU5090898A (en) Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
EP0710286A4 (en) Methods and dna expression systems for over-expression of proteins in host cells
AU3099895A (en) Genes encoding and method of expressing a novel enzyme: phthalyl amidase
AU3411889A (en) Method for the in-vivo production and testing of proteins by recombinant gene expression in selected host-cells
HUP0003541A3 (en) Expression vector for improved production of polypeptides in yeast
EP0170266A3 (en) Process for producing protein, and vector, recombinant dna and transformant used therefor
GB9309513D0 (en) Electrochemical method of modifying biomolecules in particular proteins
GB9615852D0 (en) Production of amino acids and enzymes used therefor
NZ303133A (en) glycosylated human beta interferon
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)